ONGOING STUDIES

This is a phase 4, randomized, double-blind, placebo-controlled study to evaluate the safety of 2 new 6:2 influenza virus reassortants in adults ages 18-49. There will be about 300 subjects enrolled at 2 sites in the US. The FluMist Quadrivalent nasal…

This is a phase 3, randomized, double-blind, placebo-controlled study to evaluate an investigational medication in subjects with type 2 diabetes mellitus who are not adequately controlled by metformin alone. The medication belongs to a class of diabetic medication called SGLT2…

This is a study to evaluate the safety and efficacy of a study drug vs. placebo in patients with essential hypertension who are not adequately controlled by standard of care. The trial lasts approximately 1 year and includes all study…

The Strength trial is a phase III, multi-center study enrolling patients with high triglyceride levels and low HDL cholesterol levels who have or are at risk for future cardiovascular events. The investigational product, an oral Omega-3 (study drug) or placebo…

If you don’t see a study that interests you and you’d like to be contacted about a future study for a particular indication/disease, please provide your contact info and a study coordinator will contact you.